ArticleTherapeutic advances in medical oncology2020

Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia.

Nan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.